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Ricardo Alexandre Stock*, Thaís Thumé and Elcio Luiz BonamigoAbstract
Background: Keratoconus may progress to acute corneal hydrops even after cross-linking. In some cases,
keratoconus progresses during pregnancy. In this report, we present a case of a patient with increased anterior
stromal resistance after cross-linking that would favor nonprogression of keratoconus during pregnancy.
Case presentation: We report that cross-linking is likely to have had a protective effect in a white pregnant patient
with acute corneal hydrops who showed rapid improvement, as documented by corneal topography. Improvement
occurred within 8 days, whereas up to 250 days are reported in the literature. No keratoconus progression occurred
in the 20-month follow-up period.
Conclusions: Cross-linking failed to prevent the occurrence of acute corneal hydrops after rupture of Descemet’s
membrane but most likely helped to accelerate the resolution of the condition. Corneal hardening resulting from
cross-linking may have also contributed to stabilizing keratoconus during pregnancy.
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Keratoconus is a multifactorial, noninflammatory degen-
eration of the cornea that causes a loss of stability. It is
clinically characterized by central thinning of the cornea
and irregular astigmatism, which reduce visual acuity
(VA). The treatment for keratoconus depends on its se-
verity, and corneal collagen cross-linking (CXL) is an ex-
cellent treatment option in cases of disease progression
[1]. We report a case of a pregnant patient who pro-
gressed to acute corneal hydrops after completing CXL
treatment with an unusual resolution that occurred in 8
days without scarring. Resolution normally occurs within
5 to 36 weeks with scarring [2].Case presentation
A 26-year-old white woman without systemic disease
presented with bilateral progressive keratoconus, showing
best-corrected VAs of 20/30 and 20/40 in the right eye
(RE) and left eye (LE), respectively. Corneal topography* Correspondence: ricardostockreal@gmail.com
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diopters in the RE and LE, respectively (Fig. 1a and b),
with central corneal thicknesses measured by ultrasonic
pachymetry of 471 and 484 μm for the RE and LE,
respectively.
The patient was subjected to standard protocol CXL
in both eyes and showed best-corrected VAs of 20/30
and 20/40 in the RE and LE, respectively, 3 months after
the procedure. Biomicroscopy showed a demarcation
line in the anterior stroma without haze.
The patient began using rigid contact lenses (RCLs) 5
months after the procedure and reached a VA of 20/20.
The patient returned complaining of pain, photophobia,
and low VA in her LE 7 months after undergoing CXL,
when she mentioned her 5-month pregnancy.
LE biomicroscopy showed a clinical condition of acute
corneal hydrops, with Descemet’s membrane rupture in
the central area, approximately 2 mm horizontally and 4
mm vertically, and associated stromal edema, with no
signs of inflammation in the anterior chamber (Fig. 2).
Her VA was 20/500 without correction in the LE and
20/20 in the RE with an RCL. The RE was normal, with
a well-adjusted RCL. Treatment with antibiotic eye dropsle is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
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Fig. 1 Preoperative corneal topography RE (a) and LE (b)
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tient returned 1 week later with no complaints about
the LE and showing complete resolution of the corneal
hydrops (Fig. 3).
LE corneal topography showed flattening of the
maximum corneal curvature from 54.7 diopters to
53.20 diopters (Fig. 4). The patient showed a VA of 20/20
in both eyes with RCLs.
Discussion
Hormonal effects, which remain poorly understood, are
among the factors involved in keratoconus. Studies [3, 4]
have shown that estradiol stimulates the production of
matrix metalloproteinases and the production or activation
of collagenolytic enzymes, which may be responsible for
collagen weakening. Furthermore, estrogen increases the
release of prostaglandins and activates collagenase. These
events cause collagen degradation and therefore decreased
corneal rigidity [3]. Thus, hormonal factors are related to
the onset of keratoconus, and increased estrogen (which
occurs during pregnancy) is related to its progression [4].
This case was followed for 9 months after performing CXL,
and the lack of keratoconus progression during pregnancy
was confirmed by corneal topography.Fig. 2 Descemet’s membrane ruptureOne of the most common complications of keratoco-
nus is acute corneal hydrops, which is typically corneal
edema resulting from the rupture of Descemet’s mem-
brane and endothelium [5]. Continuous intrastromal
buildup of aqueous humor causes the separation of col-
lagen lamellae and formation of fluid-filled clefts/cysts
[6]. The adjacent endothelium becomes hypertrophied in
the area of rupture of Descemet’s membrane and deter-
mines the duration of resolution of the condition (within
5 to 36 weeks) [2].
In this study, the complete resolution of the patient’s
acute corneal hydrops occurred in only 8 days. This
resolution may have resulted from prior CXL, which
promoted a photochemical reaction generating free radi-
cals and oxygen radicals [7]. The free radicals catalyze
the reaction and form covalent bonds between collagen
molecules and microfibers [8] that stabilize the stroma
and improve collagen structure, thereby hindering the
formation and persistence of corneal stromal edema [7].
Furthermore, the biomechanical effect is related to an
increase in corneal rigidity of approximately 328.9% [9].
Surprisingly, the patient progressed without haze and
with 20/20 VA with RCLs, which was confirmed by a
slit-lamp evaluation and the Snellen test.Fig. 3 Complete resolution of the condition
Fig. 4 Left eye corneal topography showing resolution of
the condition
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The present case led us to the hypothesis that CXL in-
creases anterior stromal resistance through covalent
bonds between collagen fibers. This increase in anterior
stromal resistance would obstruct the passage of aque-
ous humor after rupture of Descemet’s membrane. Fur-
thermore, increased corneal hardening would favor
keratoconus nonprogression during pregnancy. However,
other studies are necessary to determine whether CXL
accelerates the resolution of acute corneal hydrops.
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